stockrowAquestive Therapeutics, Inc. (AQST) vs Canopy Growth Corporation (CGC)
- Aquestive Therapeutics, Inc. AQST 3.64 −4.21%
- Canopy Growth Corporation CGC 0.68 −9.33%
Aquestive Therapeutics, Inc. and Canopy Growth Corporation are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. is the larger, with a market value of $460.0M against $283.5M — 1.6× the size. Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 12.5% against 7.80%. Canopy Growth Corporation has the higher net margin (−80.4% vs −162.3%) and the lower return on invested capital (−17.2% vs 0.00%). Across the 17 metrics below, Aquestive Therapeutics, Inc. leads on 9 and Canopy Growth Corporation on 8.
Valuation
Profitability
| Metric | AQST | CGC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.34% | 25.16% | 53.51% |
| Operating margin | (114.12%) | (54.89%) | 0.00% |
| Net margin | (162.33%) | (80.39%) | (2.45%) |
| Free cash flow margin | (83.33%) | (28.34%) | 0.00% |
| Return on equity | 211.59% | (40.14%) | (0.80%) |
| Return on assets | (56.05%) | (23.54%) | (1.67%) |
| Return on invested capital | 0.00% | (17.19%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack